Pyxir

Pyxir is Galixir's proprietary AI-driven drug discovery platform, built on the Chinese biotech's original algorithms combined with domain knowledge in medicinal chemistry, computational chemistry, and biology . As of a 2021 funding round led by the Shanghai AI Industry Investment Fund with follow-on from Gaorong Ventures, Source Code Capital, and 5Y Capital among others, the platform had already been validated and achieved阶段性技术进展 . 5Y Capital director Jing Xutian noted that the company was making solid commercial progress alongside its technical development, with the fresh capital earmarked for advancing multiple drug R&D pipelines and deepening its scientific edge . elsewhere's corpus does not cover more recent updates on Pyxir or Galixir's subsequent progress.